Beatriz Carvalho is a molecular biologist specialized in cancer biology, focusing in colorectal cancer (CRC) initiation/progression and translation of that knowledge in biomarkers for CRC early detection. Molecular profiling of tissues and functional studies using patient-derived organoids led to the identification of relevant biomarkers for early detection. Dr. Carvalho has actively been involved in the coordination of large prospective studies to clinically validate new tests for CRC screening and to explore the use of molecular stool tests in CRC surveillance. Dr. Carvalho is also investigating the potential of circulating tumor DNA (ctDNA) markers for multi-cancer early detection.

I am a scientist in cancer epidemiology at the International Agency for Research on Cancer. My focus is optimizing risk prediction models for cancer screening and early detection.

Rick studied mathematics and physics at Utrecht University, worked as consultant in software engineering and data analysis for a consultancy company and wrote a master thesis in an oncology research lab in Amsterdam. In 2023 he joined the Erasmus MC department of Public Health, under the supervision of Nicolien van Ravesteyn and Harry de Koning as a researcher and modeller. He loves applying his mathematical and programming knowledge on new problems, and is always interested in making new research connections to contribute and work together with others on new projects.

Ulrike Haug, a professor at Bremen University, is deputy scientific director of the Leibniz Institute for Prevention Research and Epidemiology – BIPS and heads the department Clinical Epidemiology at BIPS. She has a strong research focus on cancer screening and conducted multiple types of studies on cancer screening (particularly colorectal and breast cancer). She holds the scientific responsibility for the GePaRD database covering health claims from 20% of the German population. She is a member of national and international committees in the field of cancer prevention and screening, e.g. of the National Decade Against Cancer and the World Endoscopy Organization.

Will do

Dr. Róisín McCarthy is a Research Officer at the National Screening Service (NSS), Health Service Executive, Ireland. Róisin has a background in public health and clinical research. She is part of the Programme Evaluation Unit team at the NSS which is involved in retrieving, validating and collating data for the evaluation of the four National Screening Programmes - Breast, Bowel, Cervical, and Diabetic Retina Screening. Róisín contributes to annual reports, quality assurance meetings and research projects within her role.

Dr Therese Mooney is the Head of the Programme Evaluation Unit of the National Screening Service, Ireland. She has a PhD in Chemistry and MSc in Epidemiology from the London School of Hygiene and Tropical Medicine. She has been working in screening evaluation and research for over 20 years.

As a Master's student of Statistics from Aarhus University, Jonas felt a strong desire to put theory into practice, which led to a PhD position in the area of cancer screening epidemiology and biostatistics. Key interests are longitudinal causal inference methods.

Assoc Prof Erin Symonds completed her PhD through the University of Adelaide, with her NHMRC Post-doctoral fellowship spent in the Alimentary Pharmabiotic Centre in University College Cork, Ireland, and the Nutrigenomics and Nutrigenetics laboratory at CSIRO, Adelaide, with a strong research focus on the prevention of gastrointestinal diseases. Since 2013 she has been the lead of the Bowel Health Service group at the Flinders Centre for Innovation in Cancer. Her team’s research focus is on developing and optimising biomarkers for prevention of gastrointestinal cancers.